[{"id":"c89e4f6e-89dc-462f-b9c4-dad107cbf4e2","acronym":"ANGELICA","url":"https://clinicaltrials.gov/study/NCT05302037","created_at":"2022-03-31T18:52:43.718Z","updated_at":"2024-07-02T16:36:14.486Z","phase":"Phase 1","brief_title":"Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers","source_id_and_acronym":"NCT05302037 - ANGELICA","lead_sponsor":"CytoMed Therapeutics Pte Ltd","biomarkers":" NKG2D","pipe":"","alterations":" ","tags":["NKG2D"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CTM-N2D"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 9","initiation":"Initiation: 04/01/2022","start_date":" 04/01/2022","primary_txt":" Primary completion: 03/01/2023","primary_completion_date":" 03/01/2023","study_txt":" Completion: 12/01/2023","study_completion_date":" 12/01/2023","last_update_posted":"2022-03-31"}]